Suita, Japan

Toshihide Takeuchi

This inventor holds 1 USPTO granted patent. Top assignees: Aichi Medical University, Knc Laboratories Co., Ltd., Osaka University. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Toshihide Takeuchi. Retrieved from https://idiyas.com/inventor/toshihide-takeuchi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Toshihide Takeuchi: Innovator in Antisense Oligonucleotide Technology

Introduction

Toshihide Takeuchi is a prominent inventor based in Suita, Japan. He is recognized for his significant contributions to the field of molecular biology, particularly in the development of antisense oligonucleotides. His innovative work has the potential to impact therapeutic strategies for various diseases.

Latest Patents

Takeuchi holds a patent for an antisense oligonucleotide that controls the expression amount of TDP-43. This invention provides a suppression type antisense oligonucleotide targeting TDP-43 mRNA, which contains a nucleotide sequence complementary to a sequence consisting of at least 10 continuous nucleotides in a nucleotide sequence shown in any of SEQ ID NOs: 2-4. Additionally, it includes a promotion type antisense oligonucleotide targeting TDP-43 mRNA, containing a nucleotide sequence complementary to a sequence consisting of at least 10 continuous nucleotides in a nucleotide sequence shown in SEQ ID NO: 5.

Career Highlights

Throughout his career, Takeuchi has worked with esteemed institutions, including Osaka University and Knc Laboratories Co., Ltd. His research has focused on advancing the understanding and application of antisense technology in medical science.

Collaborations

Takeuchi has collaborated with notable colleagues such as Yoshitaka Nagai and Kazuhiro Maeta. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.

Conclusion

Toshihide Takeuchi's work in antisense oligonucleotide technology exemplifies the innovative spirit of modern science. His contributions are paving the way for new therapeutic approaches in treating diseases associated with TDP-43.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…